Work

Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?

Year: 2020

Type: article

Source: Bone Marrow Transplantation

DOI: 10.1038/s41409-020-01099-4

Authors: Sanaz Ghafouri, John Timmerman, Sarah Larson, Monica D. Mead

Institutions: UCLA Health, Ronald Reagan UCLA Medical Center, UCLA Medical Center, University of California, Los Angeles, Los Angeles Medical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3106298941

FWCI: 3.52

Cites: 12

Cited by: 56

Related to: 10